Fora Capital, LLC Repligen Corp Transaction History

Fora Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$162.42 - $220.56 $401,339 - $545,003	2,471 Added 63.15%	6,384 $1.08 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $627,723 - $1 Million	3,913 New	3,913 $732,000
Q2 2022 Aug 11, 2022	SELL	$140.68 - $188.02 $857,866 - $1.15 Million	-6,098 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$161.19 - $257.96 $982,936 - $1.57 Million	6,098 New	6,098 $1.15 Million
Q4 2021 Feb 11, 2022	SELL	$247.59 - $304.47 $587,035 - $721,898	-2,371 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $461,799 - $768,701	2,371 New	2,371 $685,000
Q4 2020 Feb 12, 2021	SELL	$148.08 - $206.57 $67,376 - $93,989	-455 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $55,742 - $72,012	455 New	455 $67 Million

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.